AllPennyStocks.com DFTX Stock Rallies As Psychedelic Drug Delivers Positive Anxiety Trial Results — Retail Says DT120 Could ‘Disrupt The Market’
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

DFTX Stock Rallies As Psychedelic Drug Delivers Positive Anxiety Trial Results — Retail Says DT120 Could ‘Disrupt The Market’

Voyage is the company’s second successful late-stage readout for DT120, following positive results in major depressive disorder in June.

Other Penny Stock Movers

Casino Tables Are Going Social, and This Microcap Just Expanded Its Reach
Canadian Defense Tech Firm Jumps 92% as Government Revenue Boosts Margins
Fiji Gold Explorer Gains 30% as Field Access Clears and Strategic Backing Closes
Most Popular
{{ index + 1 }}


Back to Top